Abingdon Health Plc
ABDX.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | £8,429 | £6,135 | £4,045 | £2,835 |
| % Growth | 37.4% | 51.7% | 42.7% | – |
| Cost of Goods Sold | £5,301 | £2,456 | £2,643 | £8,064 |
| Gross Profit | £3,128 | £3,679 | £1,402 | -£5,229 |
| % Margin | 37.1% | 60% | 34.7% | -184.4% |
| R&D Expenses | £0 | £0 | £0 | £182 |
| G&A Expenses | £7,714 | £5,070 | £5,220 | £6,645 |
| SG&A Expenses | £7,714 | £5,118 | £5,248 | £6,694 |
| Sales & Mktg Exp. | £0 | £48 | £28 | £49 |
| Other Operating Expenses | -£561 | -£66 | £0 | £0 |
| Operating Expenses | £7,153 | £5,052 | £5,248 | £6,876 |
| Operating Income | -£4,025 | -£1,373 | -£3,846 | -£12,105 |
| % Margin | -47.8% | -22.4% | -95.1% | -427% |
| Other Income/Exp. Net | £220 | -£26 | £14 | -£65 |
| Pre-Tax Income | -£3,805 | -£1,399 | -£3,574 | -£21,685 |
| Tax Expense | -£390 | -£128 | -£105 | -£331 |
| Net Income | -£3,415 | -£1,271 | -£3,469 | -£21,262 |
| % Margin | -40.5% | -20.7% | -85.8% | -750% |
| EPS | -0.009 | -0.004 | -0.011 | -0.073 |
| % Growth | -121.4% | 63.2% | 84.4% | – |
| EPS Diluted | -0.009 | -0.004 | -0.011 | -0.073 |
| Weighted Avg Shares Out | 366,658 | 304,732 | 304,033 | 291,623 |
| Weighted Avg Shares Out Dil | 366,658 | 304,732 | 305,820 | 291,623 |
| Supplemental Information | – | – | – | – |
| Interest Income | £100 | £31 | £89 | £4 |
| Interest Expense | £75 | £57 | £75 | £69 |
| Depreciation & Amortization | £608 | £426 | £688 | £1,637 |
| EBITDA | -£3,122 | -£916 | -£2,811 | -£19,979 |
| % Margin | -37% | -14.9% | -69.5% | -704.7% |